WallStreetZenWallStreetZen

NASDAQ: TNYA
Tenaya Therapeutics Inc Stock Ownership - Who owns Tenaya Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tenaya Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Faraz AliChief Executive Officer2026-05-183,390$0.79
$2.69kSell
Whittemore TingleyChief Medical Officer2026-05-183,121$0.79
$2.48kSell
Tomohiro HigaSVP Finance2026-05-181,485$0.79
$1.18kSell
Column Group III GP LP10% Owner2026-02-251,649,281$0.56
$926.90kSell
Column Group III GP LP10% Owner2026-02-251,862,545$0.56
$1.05MSell
Column Group III GP LP10% Owner2026-02-24349,212$0.62
$214.77kSell
Column Group III GP LP10% Owner2026-02-24309,228$0.62
$190.18kSell
Column Group III GP LP10% Owner2026-02-23162,291$0.60
$96.89kSell
Column Group III GP LP10% Owner2026-02-23143,709$0.60
$85.79kSell
Column Group III GP LP10% Owner2026-02-20277,769$0.62
$170.83kSell

1 of 4

TNYA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TNYA insiders and whales buy or sell their stock.

TNYA Shareholders

What type of owners hold Tenaya Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Column Group III GP LP26.39%59,183,833$42.97MInsider
David V. Goeddel6.63%14,855,844$10.79MInsider
Vanguard Capital Management LLC3.78%8,482,288$6.16MInstitution
Eli Casdin2.87%6,440,829$4.68MInsider
Millennium Management LLC2.43%5,456,666$3.96MInstitution
Empery Asset Management LP1.91%4,286,933$3.11MInstitution
Citadel Advisors LLC1.87%4,200,000$3.05MInstitution
Renaissance Technologies LLC1.66%3,713,761$2.70MInstitution
Blackrock Inc1.65%3,703,955$2.69MInstitution
Marshall Wace LLP1.21%2,705,390$1.96MInstitution

1 of 3

TNYA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TNYA24.22%36.93%Net SellingNet Selling
YDES0.23%3.73%
CRBU38.16%8.68%Net Selling
IPHA0.20%0.00%
HUMA26.58%13.84%Net SellingNet Selling
View Top Biotech Stocks

Tenaya Therapeutics Stock Ownership FAQ

Who owns Tenaya Therapeutics?

Tenaya Therapeutics (NASDAQ: TNYA) is owned by 24.22% institutional shareholders, 36.93% Tenaya Therapeutics insiders, and 38.85% retail investors. Column Group III GP LP is the largest individual Tenaya Therapeutics shareholder, owning 59.18M shares representing 26.39% of the company. Column Group III GP LP's Tenaya Therapeutics shares are currently valued at $43.03M.

If you're new to stock investing, here's how to buy Tenaya Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.